These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 11511795

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas.
    Watanabe K, Tachibana O, Sata K, Yonekawa Y, Kleihues P, Ohgaki H.
    Brain Pathol; 1996 Jul; 6(3):217-23; discussion 23-4. PubMed ID: 8864278
    [Abstract] [Full Text] [Related]

  • 3. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
    Lang FF, Miller DC, Koslow M, Newcomb EW.
    J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Determination of p53 mutations, EGFR overexpression, and loss of p16 expression in pediatric glioblastomas.
    Sure U, Rüedi D, Tachibana O, Yonekawa Y, Ohgaki H, Kleihues P, Hegi ME.
    J Neuropathol Exp Neurol; 1997 Jul; 56(7):782-9. PubMed ID: 9210874
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Necrogenesis and Fas/APO-1 (CD95) expression in primary (de novo) and secondary glioblastomas.
    Tohma Y, Gratas C, Van Meir EG, Desbaillets I, Tenan M, Tachibana O, Kleihues P, Ohgaki H.
    J Neuropathol Exp Neurol; 1998 Mar; 57(3):239-45. PubMed ID: 9600216
    [Abstract] [Full Text] [Related]

  • 13. Molecular pathogenesis of pediatric astrocytic tumors.
    Nakamura M, Shimada K, Ishida E, Higuchi T, Nakase H, Sakaki T, Konishi N.
    Neuro Oncol; 2007 Apr; 9(2):113-23. PubMed ID: 17327574
    [Abstract] [Full Text] [Related]

  • 14. Pediatric glioblastomas: a histopathological and molecular genetic study.
    Suri V, Das P, Pathak P, Jain A, Sharma MC, Borkar SA, Suri A, Gupta D, Sarkar C.
    Neuro Oncol; 2009 Jun; 11(3):274-80. PubMed ID: 18981259
    [Abstract] [Full Text] [Related]

  • 15. DJ-1 expression in glioblastomas shows positive correlation with p53 expression and negative correlation with epidermal growth factor receptor amplification.
    Hinkle DA, Mullett SJ, Gabris BE, Hamilton RL.
    Neuropathology; 2011 Feb; 31(1):29-37. PubMed ID: 20497343
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas.
    Frederick L, Wang XY, Eley G, James CD.
    Cancer Res; 2000 Mar 01; 60(5):1383-7. PubMed ID: 10728703
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Amplification of the epidermal growth factor receptor gene in glioblastoma: an analysis of the relationship between genotype and phenotype by CISH method.
    Miyanaga T, Hirato J, Nakazato Y.
    Neuropathology; 2008 Apr 01; 28(2):116-26. PubMed ID: 18021194
    [Abstract] [Full Text] [Related]

  • 20. Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival.
    Eoli M, Menghi F, Bruzzone MG, De Simone T, Valletta L, Pollo B, Bissola L, Silvani A, Bianchessi D, D'Incerti L, Filippini G, Broggi G, Boiardi A, Finocchiaro G.
    Clin Cancer Res; 2007 May 01; 13(9):2606-13. PubMed ID: 17473190
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.